2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neuroendocrine Tumors
12
Neoplasms
8
Carcinoid Tumor
7
Diarrhea
6
Colorectal Neoplasms
6
Carcinoma, Hepatocellular
6
Breast Neoplasms
5
Acromegaly
5
Vipoma
4
Stomach Neoplasms
4
Somatostatinoma
4
Rectal Neoplasms
4
Insulinoma
4
Glucagonoma
4
Gastro-enteropancreatic neuroendocrine tumor
4
Esophageal Neoplasms
4
Carcinoma, Islet Cell
4
Adenoma, Islet Cell
4
Weight Loss
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Intestinal Obstruction
3
Gastrinoma
3
Colonic Neoplasms
3
Carcinoma
3
Thymoma
2
Pituitary Neoplasms
2
Ovarian Neoplasms
2
Meningioma
2
Interventions
Metformin
30
Exercise
8
Pioglitazone
7
Inositol
6
Insulin
5
Acupuncture Therapy
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
drospirenone and ethinyl estradiol combination
2
Water
2
Tablets
2
Surveys and Questionnaires
2
Sugars
2
Resistance Training
2
Preoperative Exercise
2
Observation
2
Folic Acid
2
Diet Therapy
2
Cyproterone Acetate
2
Cholecalciferol
2
Caloric Restriction
2
Biguanides
2
ziprasidone
1
maltodextrin
1
lime
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Insulin Resistance
×
Octreotide
×
Clear all
NCT03734627
2021-08-16
EndoGut
St. James's Hospital, Ireland
Completed
40 enrolled